ArticleDiscover oncology2022

Changes in neutrophile-to-lymphocyte ratio as predictive and prognostic biomarker in metastatic prostate cancer treated with taxane-based chemotherapy.

Manuel Neuberger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.